Series A Healthcare Montreal, QC, Canada

Non-Invasive Diagnostic Ultrasound for Cardiac Care

MediPulse BioDevices

Executive Summary

Handheld point-of-care cardiac diagnostic system leveraging edge computing to provide ICU-quality imaging at bedside.

The company has engineered a proprietary competitive moat backed by defensible intellectual property and strategic pilot engagements. With an expanding customer pipeline and verified unit economics, capital deployed in this round directly accelerates manufacturing scale and North American commercial distribution.

Investment Highlights & Milestones

Health Canada & FDA 510(k) approval pathway initiated

Completed 280-patient clinical trial with 99.1% diagnostic fidelity

Over $600K in non-dilutive federal grants received

Deal Terms & Security Offering

Financing Instrument Series A Preferred Equity

Securities Exemption NI 45-106 Accredited

Target Close Window 45 Days

Round Status Actively Syndicating

Committed 70% of Goal

Target Capital Ask: CA$ 3,000,000

Capital Raised: CA$ 2,100,000

Min. Check Size: CA$ 50,000

Financial statements and full cap table accessible to certified accredited investors following NDA acknowledgment.

Leadership & Founder

Dr. Aris Thorne

Chief Medical Officer & Founder

Experienced technologist and serial entrepreneur with deep technical domain expertise and executive leadership across commercial manufacturing.

Canada’s Leading Venture Marketplace

Ready to Back or Build the Next Market Champion?

Join over 15,200 accredited private angels and thousands of Canadian founders already collaborating on deals that shape our economic future.

Registration is free for investors. Pitches subject to due diligence verification prior to publishing.